Alnylam Pharmaceuticals
ALNY
#627
Rank
S$43.13 B
Marketcap
$334.40
Share price
6.20%
Change (1 day)
51.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: S$43.13 Billion

As of November 2024 Alnylam Pharmaceuticals has a market cap of S$43.13 Billion. This makes Alnylam Pharmaceuticals the world's 627th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024S$43.13 B35.96%
2023S$31.72 B-19.06%
2022S$39.19 B42.95%
2021S$27.41 B37.26%
2020S$19.97 B14.68%
2019S$17.41 B72.85%
2018S$10.07 B-40.2%
2017S$16.85 B262.41%
2016S$4.64 B-58.96%
2015S$11.33 B14.51%
2014S$9.89 B90.55%
2013S$5.19 B343.28%
2012S$1.17 B159.77%
2011S$0.45 B-16.15%
2010S$0.53 B-48.03%
2009S$1.03 B-29.34%
2008S$1.46 B-14.16%
2007S$1.70 B40.33%
2006S$1.21 B183.44%
2005S$0.42 B82.53%
2004S$0.23 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

S$43.13 Billion
by Yahoo Finance info icon info icon
S$43.13 Billion
by CompaniesMarketCap info icon info icon
S$43.13 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$3.12 B-92.75%๐Ÿ‡บ๐Ÿ‡ธ USA
S$109.79 B 154.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.23 B-67.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.42 B-96.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.12 B-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$277.11 B 542.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$162.81 B 277.50%๐Ÿ‡ซ๐Ÿ‡ท France
S$25.93 B-39.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel